---
title: "SEA STAR released its first-quarter performance, with a net profit attributable to the parent company of 13.2666 million yuan, a year-on-year increase of 19.21%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236814196.md"
description: "According to the Zhitong Finance APP, SEA STAR released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 141 million yuan, a year-on-year decrease of 10.51%. The net profit attributable to shareholders of the listed company was 13.2666 million yuan, a year-on-year increase of 19.21%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 7.4888 million yuan, a year-on-year decrease of 13.16%"
datetime: "2025-04-21T14:25:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236814196.md)
  - [en](https://longbridge.com/en/news/236814196.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236814196.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/236814196.md) | [繁體中文](https://longbridge.com/zh-HK/news/236814196.md)


# SEA STAR released its first-quarter performance, with a net profit attributable to the parent company of 13.2666 million yuan, a year-on-year increase of 19.21%

According to the Zhitong Finance APP, SEA STAR (002137.SZ) released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 141 million yuan, a year-on-year decrease of 10.51%. The net profit attributable to shareholders of the listed company was 13.2666 million yuan, a year-on-year increase of 19.21%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 7.4888 million yuan, a year-on-year decrease of 13.16%

### Related Stocks

- [SEA STAR (002137.CN)](https://longbridge.com/en/quote/002137.CN.md)

## Related News & Research

- [Kansas City International Airport reopens after brief closure due to unspecified threat](https://longbridge.com/en/news/278278269.md)
- [BYD reportedly explores F1 entry to boost global brand appeal](https://longbridge.com/en/news/278576491.md)
- [Indel B Adds to Treasury Stock with New Share Buybacks on Euronext Milan](https://longbridge.com/en/news/278778618.md)
- [Junshi Biosciences’ Subcutaneous Toripalimab NDAs Accepted in China](https://longbridge.com/en/news/278445287.md)
- [Kainova reports positive top line results from Phase I EPRAD trial](https://longbridge.com/en/news/278702903.md)